Ampoule Bottle Market Report 2026

The ampoule bottle market size has grown strongly in recent years. It will grow from $11.24 billion in 2025 to $11.8 billion in 2026 at a compound annual growth rate (CAGR) of 5%. The growth in the historic period can be attributed to expansion of pharmaceutical manufacturing, growth in injectable drug usage, rising vaccination programs, availability of glass packaging infrastructure, increased hospital and clinical demand.

The ampoule bottle market size is expected to see steady growth in the next few years. It will grow to $14.17 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to increasing development of biologics and vaccines, rising preference for lightweight packaging, expansion of contract pharmaceutical manufacturing, growing focus on sustainable packaging materials, increasing automation in pharma packaging. Major trends in the forecast period include increasing demand for sterile single-dose packaging, rising adoption of plastic ampoule alternatives, growing use of amber and protective packaging, expansion of automated filling and sealing lines, enhanced focus on contamination prevention.

The rising demand from the pharmaceutical industry is expected to drive the growth of the ampoule bottle market in the coming years. The pharmaceutical industry comprises activities related to the research, development, manufacturing, and distribution of drugs and medications used for the prevention, diagnosis, treatment, and cure of diseases. The growing demand from pharmaceutical companies is driven by factors such as an aging population, the increasing prevalence of chronic diseases, advancements in medical technologies, improved access to healthcare services, and heightened awareness of health and wellness. Ampoule bottles support the pharmaceutical industry by offering a secure and sterile packaging solution that helps maintain the integrity, effectiveness, and shelf life of medications, ensuring that sensitive drugs remain stable and uncontaminated during storage and transportation. For instance, in April 2025, according to Eurostat, a Luxembourg-based government agency, EU exports of medicinal and pharmaceutical products rose by 13.5% in 2024 compared with 2023, reaching $316.38 billion (€313.4 billion), while imports recorded only a marginal increase of 0.5% to $112.7 billion (€119.7 billion). Consequently, the expanding pharmaceutical industry is contributing to the growth of the ampoule bottle market.

The ampoule bottle market is witnessing a notable trend toward the expansion of high-quality pharmaceutical glass tubing production to address rising demand. Companies in the market are emphasizing the development of advanced packaging solutions, including high-quality pharmaceutical glass tubing, to improve drug safety, enhance product stability, and comply with the stringent regulatory requirements of the pharmaceutical sector. High-quality pharmaceutical glass tubing refers to specially engineered, durable glass tubes designed for pharmaceutical use, offering superior safety, chemical resistance, and adherence to strict industry standards for effective medication storage and packaging. For example, in March 2023, Schott, a Germany-based manufacturing company, initiated the production of amber pharma glass in India to meet growing market demand. The company invested €75 million (approximately INR 660 crore) to expand its Gujarat facility, doubling its borosilicate glass tubing production capacity. This premium-quality glass is used in the manufacturing of pharmaceutical containers such as vials and ampoules for storing critical medications. FIOLAX borosilicate glass is recognized for its high performance and integrates advanced Indian and European technologies to meet international standards, while the facility employs automation and smart manufacturing solutions, including PerfeXion, to ensure enhanced quality control.

In June 2024, Dec Group, a Switzerland-based provider of advanced powder handling and process solutions, acquired Bausch GmbH for an undisclosed amount. Through this acquisition, Dec Group aims to strengthen its aseptic processing capabilities by offering more advanced and integrated solutions, particularly in powder dispensing applications. Bausch GmbH is a Germany-based manufacturer specializing in ampoule bottles.

Major companies operating in the ampoule bottle market are Nipro Pharma Packaging International NV, Gerresheimer AG, Stevanato Group, Schott Pharma, Shandong Pharmaceutical Glass Co, SGD Pharma, Borosil Glass Works Ltd., DWK Life Sciences GmbH, Meech, Adelphi Healthcare Packaging, Solopharm, Contract Pharma, AAPL Solutions, Crestani S.r.l, J.Penner Corporation, Sandfire Scientific Ltd., Uhlmann Gmbh, Dai-ichi Glass Co. Ltd., Global Pharmatech Pvt. Ltd., Nurrin pharmalab Pty. Ltd.

North America was the largest region in the ampoule bottle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ampoule bottle market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ampoule bottle market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ampoule bottle market consists of sales of ampoule vials, open ampoules, closed ampoules, and pre-scored ampoules. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.